MA39965A - Dérivés de tétrahydrotriazolopyrimidine, compositions pharmaceutiques les contenant et utilisations - Google Patents

Dérivés de tétrahydrotriazolopyrimidine, compositions pharmaceutiques les contenant et utilisations

Info

Publication number
MA39965A
MA39965A MA039965A MA39965A MA39965A MA 39965 A MA39965 A MA 39965A MA 039965 A MA039965 A MA 039965A MA 39965 A MA39965 A MA 39965A MA 39965 A MA39965 A MA 39965A
Authority
MA
Morocco
Prior art keywords
tetrahydrotriazolopyrimidine
derivatives
contain
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
MA039965A
Other languages
English (en)
Inventor
Elisabetta Armani
Carmelida Capaldi
Robert Andrew Heald
Jonathan Mark Sutton
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA39965A publication Critical patent/MA39965A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA039965A 2014-06-12 2015-06-12 Dérivés de tétrahydrotriazolopyrimidine, compositions pharmaceutiques les contenant et utilisations MA39965A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14172176 2014-06-12

Publications (1)

Publication Number Publication Date
MA39965A true MA39965A (fr) 2021-04-28

Family

ID=50933039

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039965A MA39965A (fr) 2014-06-12 2015-06-12 Dérivés de tétrahydrotriazolopyrimidine, compositions pharmaceutiques les contenant et utilisations

Country Status (11)

Country Link
US (1) US9487528B2 (fr)
EP (1) EP3154980B1 (fr)
KR (1) KR20170012258A (fr)
CN (1) CN106459065A (fr)
AR (1) AR100794A1 (fr)
CA (1) CA2951743A1 (fr)
MA (1) MA39965A (fr)
MX (1) MX2016016381A (fr)
RU (1) RU2016148397A (fr)
TW (1) TW201625627A (fr)
WO (1) WO2015189362A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB0605469D0 (en) * 2006-03-17 2006-04-26 Argenta Discovery Ltd Multimers of heterocyclic compounds and their use
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
WO2007129060A1 (fr) 2006-05-04 2007-11-15 Argenta Discovery Limited Tétrahydropyrrolopyrimidinediones et leur utilisation comme inhibiteurs de l'élastase neutrophile humaine
GB201004179D0 (en) * 2010-03-12 2010-04-28 Pulmagen Therapeutics Inflamma Enzyme inhibitors
GB201004178D0 (en) 2010-03-12 2010-04-28 Pulmagen Therapeutics Inflamma Enzyme inhibitors
AR087841A1 (es) 2011-09-14 2014-04-23 Chiesi Farma Spa Derivados de tetrahidrotriazolopirimidina
BR112015000507A2 (pt) 2012-07-12 2017-06-27 Chiesi Farm Spa inibição de enzimas
GEP20186885B (en) 2012-12-18 2018-08-10 Chiesi Farma Spa Novel compounds
EP3083626B1 (fr) 2013-12-16 2017-10-25 CHIESI FARMACEUTICI S.p.A. Derives de tetrahydrotriazolopyrimidine en tant qu'inhibiteurs de l'elastase neutrophile humaine

Also Published As

Publication number Publication date
AR100794A1 (es) 2016-11-02
KR20170012258A (ko) 2017-02-02
CN106459065A (zh) 2017-02-22
CA2951743A1 (fr) 2015-12-17
TW201625627A (zh) 2016-07-16
US20150353561A1 (en) 2015-12-10
MX2016016381A (es) 2017-05-01
RU2016148397A (ru) 2018-07-18
US9487528B2 (en) 2016-11-08
EP3154980A1 (fr) 2017-04-19
WO2015189362A1 (fr) 2015-12-17
EP3154980B1 (fr) 2021-08-04

Similar Documents

Publication Publication Date Title
MA45188A (fr) Oligonucléotides, compositions et méthodes associées
BR112017023853A2 (pt) composições de nanopartícula para terapia sustentada.
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3529248T3 (da) Farmaceutiske sammensætninger
BR112016023628A2 (pt) composições farmacêuticas.
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
MA50541A (fr) Formulations pharmaceutiques
BR112016022062A2 (pt) Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico
BR112017005255A2 (pt) composições não gordurosas de cuidado pessoal.
MA54254A (fr) Dérivés de benzodiazépine cytotoxique
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
MA42303A (fr) Formulations pharmaceutiques
MA54716A (fr) Réduction de la viscosité de formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
MA45187A (fr) Combinaisons pharmaceutiques
MA49837A (fr) Compositions pharmaceutiques
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
BR112016026552A2 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
IL248773B (en) History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them
DK3389633T3 (da) Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat
DK3191085T3 (da) Misbrugsresistente farmaceutiske sammensætninger
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning